Search results for "malattie"

showing 10 items of 1963 documents

Survival in young patients with intermediate-/high-risk myelofibrosis: Estimates derived from databases for non transplant patients

2009

Recent studies have suggested that allogenic stem cell transplantation (allo-SCT) might be a better treatment option, compared to drug therapy, for young patients with high-/intermediate-risk primary myelofibrosis (PMF). However, there are no controlled studies that validate this contention and allo-SCT is associated with a substantial risk of procedure-related mortality and morbidity. In a retrospective analysis of nontransplant PMF patients, who were both young (age <60 years) and with high-/intermediate-risk disease, 1- and 3-year survival estimates were 87% and 55%, 95% and 77%, 71% and 58%, respectively, involving patients seen at three different centers with expertise in PMF; these da…

AdultMalemedicine.medical_specialtyTransplantation ConditioningAdolescentmedicine.medical_treatmentbone marrow transplantationContext (language use)myelofibrosisHematopoietic stem cell transplantationKaplan-Meier EstimateSettore MED/15 - Malattie Del Sanguemyelofibrosis survivalYoung AdultPharmacotherapyInternal medicinemedicineHumansTransplantation HomologousYoung adultMyelofibrosisRetrospective Studiesbusiness.industryAge FactorsHematopoietic Stem Cell TransplantationRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurgeryTransplantationmyelofibrosis; bone marrow transplantationPrimary MyelofibrosisFemaleTransplantation ConditioningbusinessFollow-Up Studies
researchProduct

The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure

2010

Aims According to the current guidelines, the patent foramen ovale (PFO) is still considered a qualitative factor and, as a consequence, its closure is recommended just on the basis of its ‘presence’. Methods and results In the year 2008, we evaluated 25 patients (mean age 62.7) with acute cerebrovascular event and 92 patients (mean age 27.3) suffering from migraine with aura. No PFO was reported in 79 patients. A venous-to-arterial circulation shunt had been shown in 38 patients (29 subjects with migraine and 9 subjects with prior stroke). According to the number of microbubbles arrived during the Valsava manoeuvre, we found: 25 small PFO, 6 moderate PFO, and 6 severe PFO. In the baseline …

AdultMalemedicine.medical_specialtyValsalva ManeuverMigraine with AuraPopulationForamen Ovale PatentRisk AssessmentBrain IschemiaRisk FactorsIschaemic strokeConfidence IntervalsOdds RatiomedicineForamenHumansRadiology Nuclear Medicine and imagingeducationeducation.field_of_studybusiness.industryMean ageGeneral MedicineMiddle AgedPrognosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMigraine with auraSurgeryItalyMigraineEchocardiographyCase-Control StudiesMultivariate AnalysisIschemic strokePatent foramen ovaleFemalePFOevaluationmedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients.

2019

Background: Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease characterized by a significant impairment of patients’ quality of life (QoL). It has been recently found that clinical severity of HS does not correlate well with QoL. Therefore, it is important to enhance the evaluation of severity considering the disease burden on QoL. Recently, a new graphical tool able to better describe HS burden, the so-called HIDRAdisk, has been introduced. Objective: To investigate the utility of HIDRAdisk in clinical practice before and after treatment and to analyse whether specific factors such as age and gender may influence the outcomes in patients with moderate-to-severe…

AdultMalemedicine.medical_specialtyVisual Analog ScaleDermatology.Severity of Illness IndexAge and gender030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsDisease severityQuality of lifeHidradenitis suppurativa quality of lifeCost of IllnessInternal medicinemedicineAdalimumabHumansIn patientHidradenitis suppurativa030212 general & internal medicineDisease burdenRetrospective Studiesbusiness.industryAge FactorsRetrospective cohort studyMiddle Agedmedicine.diseaseHidradenitis SuppurativaInfectious DiseasesTreatment OutcomeQuality of LifeFemalebusinessSettore MED/35 - MALATTIE CUTANEE E VENEREEHIDRAdisk outcomesmedicine.drughidradiskJournal of the European Academy of Dermatology and Venereology : JEADVReferences
researchProduct

Gag reflex control through acupuncture: a case series.

2014

Background Many patients avoid dental appointments because of severe gagging when they have work performed, such as taking impressions. There are several methods known to alleviate gagging, and some studies have suggested that acupuncture may be effective in reducing gag reflex. The aim of the present study therefore was to evaluate whether acupuncture can produce a reduction of the gag reflex. Methods A total of 20 patients, aged between 19 and 80 years, with history of gag reflex on taking dental impressions, were recruited. All patients fulfilling the inclusion criteria had an upper and lower dental alginate impression taken without acupuncture, and a second upper and lower alginate impr…

AdultMalemedicine.medical_specialtyVisual analogue scaleAcupuncture TherapyTraditional Chinese medicineGaggingYoung AdultPharyngeal reflexSettore MED/28 - Malattie OdontostomatologicheSensationAcupuncturemedicineHumansYoung adultAgedAged 80 and overCross-Over Studiesbusiness.industryGeneral MedicineMiddle AgedCrossover studydental surgeryClinical trialtaking impressingComplementary and alternative medicinePhysical therapyFemaleNeurology (clinical)gag-reflexbusinessacupunctureAcupuncture in medicine : journal of the British Medical Acupuncture Society
researchProduct

Alveolar nitric oxide and asthma control in mild untreated asthma

2012

Background The role of the peripheral airways in asthma is increasingly being recognized as a potential target for the achievement of optimal control of the disease. We postulated that the inflammatory changes of the small airways are implicated in the lack of asthma control in mild asthma. Objective To test this hypothesis, we measured the alveolar fraction of exhaled NO (C alv NO) in patients with mild asthma with different levels of control of symptoms. Methods Seventy-eight patients with asthma (35 men, age, 37 ± 15 years; FEV 1 percentage of predicted, 100% ± 9%) were studied. Asthma control was assessed by using the Asthma Control Test (ACT). Measurements of exhaled NO at multiple con…

AdultMalemedicine.medical_specialtyVital capacityImmunologySettore MED/10 - Malattie Dell'Apparato RespiratorioNitric OxideGastroenterologyNitric oxideYoung Adultchemistry.chemical_compoundFEV1/FVC ratioAsthma controlInternal medicinemedicineHumansImmunology and AllergyYoung adultAsthmabusiness.industryExhalationmedicine.diseaseAsthmaRespiratory Function Testsrespiratory tract diseaseschemistryExhalationAnesthesiaFemalebusinessAsthma Control TestJournal of Allergy and Clinical Immunology
researchProduct

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.

2011

Abstract The safest duration of anticoagulation after idiopathic deep vein thrombosis (DVT) is unknown. We conducted a prospective study to assess the optimal duration of vitamin K antagonist (VKA) therapy considering the risk of recurrence of thrombosis according to residual vein thrombosis (RVT). Patients with a first unprovoked DVT were evaluated for the presence of RVT after 3 months of VKA administration; those without RVT suspended VKA, while those with RVT continued oral anticoagulation for up to 2 years. Recurrent thrombosis and/or bleeding events were recorded during treatment (RVT group) and 1 year after VKA withdrawal (both groups). Among 409 patients evaluated for unprovoked DVT…

AdultMalemedicine.medical_specialtyVitamin Kmedicine.drug_classDeep veinHemorrhageDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRecurrenceRisk Factorsdeep vein thrombosis (DVT)Residual vein thrombosismedicineHumansProspective Studiesdeep vein thrombosis (DVT); vitamin K antagonist (VKA) therapy; Residual vein thrombosisProspective cohort studyAgedUltrasonographyVenous Thrombosisbusiness.industryAcenocoumarolAnticoagulantsHematologyVenous ThromboembolismVitamin K antagonistMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryClinical trialVein thrombosisvitamin K antagonist (VKA) therapymedicine.anatomical_structureLower ExtremityRelative riskFemaleWarfarinbusiness
researchProduct

Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea

2013

Obstructive sleep apnea often coexists with visceral adiposity and metabolic syndrome. In this study, we analysed gender-related differences in anthropometrics according to sleep apnea severity and metabolic abnormalities. In addition, the visceral adiposity index, a recently introduced marker of cardiometabolic risk, was analysed. Consecutive subjects with suspected obstructive sleep apnea (n = 528, 423 males, mean age ± standard deviation: 51.3 ± 12.8 years, body mass index: 31.0 ± 6.2 kg m(-2) ) were studied by full polysomnography (apnea-hypopnea index 43.4 ± 27.6 h(-1) ). Variables of general and visceral adiposity were measured (body mass index, neck, waist and hip circumferences, wai…

AdultMalemedicine.medical_specialtyWaistPolysomnographyCognitive NeuroscienceBlood PressurePolysomnographySettore MED/10 - Malattie Dell'Apparato Respiratorioreceiving-operator characteristic curveCardiovascular SystemBody Mass IndexBehavioral NeuroscienceInsulin resistanceInternal medicinemedicineHumansObesityAdiposityMetabolic SyndromeSex CharacteristicsSleep Apnea ObstructiveAnthropometrymedicine.diagnostic_testWaist-Hip Ratiobusiness.industryMetabolic Syndrome XSleep apneaGeneral MedicineSex CharacteristicMiddle Agedmedicine.diseaseObesityrespiratory tract diseasesObstructive sleep apneaEndocrinologyfat distributionBiological MarkerCardiologyFemalewomenWaist CircumferenceInsulin ResistanceMetabolic syndromebusinessBody mass indexBiomarkersHumanJournal of Sleep Research
researchProduct

Echocardiographic reference ranges for normal left ventricular layer-specific strain: results from the EACVI NORRE study

2020

Abstract Aims  To obtain the normal range for 2D echocardiographic (2DE) measurements of left ventricular (LV) layer-specific strain from a large group of healthy volunteers of both genders over a wide range of ages. Methods and results  A total of 287 (109 men, mean age: 46 ± 14 years) healthy subjects were enrolled at 22 collaborating institutions of the EACVI Normal Reference Ranges for Echocardiography (NORRE) study. Layer-specific strain was analysed from the apical two-, three-, and four-chamber views using 2DE software. The lowest values of layer-specific strain calculated as ±1.96 standard deviations from the mean were −15.0% in men and −15.6% in women for epicardial strain, −16.8% …

AdultMalemedicine.medical_specialtyadult echocardiographydeformation imagingHeart Ventricles030204 cardiovascular system & hematologyVentricular Function LeftReference values2D echocardiography03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicinereference values.Healthy volunteersmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineEndocardiumNormal rangeStrain (chemistry)business.industryMyocardiumHealthy subjectsreference valueMean ageGeneral MedicineMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREMiddle AgedApex (geometry)EchocardiographyCardiology[SDV.IB]Life Sciences [q-bio]/BioengineeringFemalebusinessLarge groupCardiology and Cardiovascular MedicineEndocardiumHuman
researchProduct

Two-dimensional echocardiographic evaluation of left ventricular ejection fraction by the ellipsoid single-plane algorithm: a reliable method for ass…

1995

The reliability of two-dimensional (2D) echocardiographic estimation of left ventricular ejection fraction (EF) is commonly recognized, but no satisfactory data are available about the accuracy of low or very low EF values determined by 2D echocardiography (ECHO-EF). The purpose of our study was to assess the reliability of low ECHO-EF values obtained using a simple time-economical algorithm such as the ellipsoid single-plane area-length method. Radionuclide angiography (RAD-EF) was taken as the standard of comparison. We studied 59 consecutive patients (31 women and 28 men) referred to our echocardiographic laboratory. Both 2D echocardiography and radionuclide angiography were blindly perf…

AdultMalemedicine.medical_specialtyanimal structuresSettore MED/09 - Medicina InternaCardiac Output LowVentricular Function LeftVentricular Dysfunction LeftRadionuclide angiographyVentricule gaucheReference ValuesInternal medicinemedicineHumansPharmacology (medical)AgedEjection fractionmedicine.diagnostic_testPlane (geometry)business.industryTwo dimensional echocardiographyReproducibility of ResultsGated Blood-Pool ImagingSignal Processing Computer-AssistedStroke VolumeMiddle AgedEllipsoidSettore MED/11 - Malattie Dell'Apparato CardiovascolareArea length methodTwo dimensional echocardiography Area-lenght method Radionuclide angiography Ejection fraction Regression analysisEchocardiographyCardiologyFemaleCardiology and Cardiovascular MedicinebusinessNuclear medicineAlgorithms
researchProduct

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation base…

2008

Abstract Residual vein thrombosis (RVT) indicates a prothrombotic state and is useful for evaluating the optimal duration of oral anticoagulant treatment (OAT). Patients with a first episode of deep vein thrombosis, treated with OAT for 3 months, were managed according to RVT findings. Those with RVT were randomized to either stop or continue anticoagulants for 9 additional months, whereas in those without RVT, OAT was stopped. Outcomes were recurrent venous thromboembolism and/or major bleeding. Residual thrombosis was detected in 180 (69.8%) of 258 patients; recurrent events occurred in 27.2% of those who discontinued (25/92; 15.2% person-years) and 19.3% of those who continued OAT (17/88…

AdultMalemedicine.medical_specialtymedicine.drug_classDeep veinImmunologyHemorrhageBiochemistryDrug Administration ScheduleSettore MED/15 - Malattie Del SangueDeep vein thrombosioral anticoagulantSecondary PreventionmedicineHumansAgedUltrasonographyVenous ThrombosisFirst episoderesidual vein thrombosisVascular diseasebusiness.industryAnticoagulantHazard ratioAnticoagulantsCell BiologyHematologyMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosisConfidence intervalSurgeryVenous thrombosisTreatment Outcomemedicine.anatomical_structureFemalebusinessBlood
researchProduct